Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 26, 2026

Conduent (CNDT): +34% Gain in 30 Days Driven by Undervaluation Recognition

Key Takeaways

  • CNDT stock rose +34% over the past 30 days, driven by recognition of its undervaluation and leadership in healthcare payer operations.
  • Over the past quarter, shares gained +1%, amid volatile trading with a dip following Q4 earnings before a partial recovery.
  • Strong new business annual contract value (ACV) growth and institutional ownership supported sentiment.
  • Q4 results showed revenue stability but an earnings miss, contributing to early-quarter pressure.
  • Positive analyst commentary highlighted trading at a deep discount to intrinsic value.

Conduent (CNDT): Company Overview and Market Position

Conduent Incorporated (CNDT) delivers digital business solutions and services across commercial, government, and transportation sectors. The company focuses on transaction-intensive processing, analytics, and automation, enabling clients to streamline operations and gain data-driven insights. From what I see, Conduent maintains a solid position in the competitive business process services industry through long-term contracts with government entities and key strengths in healthcare payer operations and transportation management. Its recurring revenue from government deals provides stability, and the recent push into AI-driven automation aligns well with industry trends, which helps account for its resilience despite stock volatility.

CNDT Stock Performance: Last 30 Days vs. Quarter

Over the last 30 days, CNDT stock climbed from approximately $1.27 to $1.70, marking a +34% gain. The uptrend was volatile, with shares rebounding sharply from mid-March lows around $1.15, backed by steady volume increases and momentum toward recent highs near $1.76.

Looking at the past quarter, shares edged up +1% from about $1.68 to $1.70. Trading stayed range-bound with elevated volatility, including a drop to $1.15 in mid-March before a recovery, as broader pressures were countered by selective buying interest.

Drivers Behind CNDT's 30-Day Rally

The +34% surge in CNDT stock over the last 30 days came from investors increasingly recognizing the company's undervaluation. One analysis pointed out the stock trading at a deep discount to its long-term intrinsic value, with a one-month return exceeding 32% as of mid-April, which fueled buying momentum. Conduent's status as a leader in Everest Group's 2026 Healthcare Payer Intelligent Operations PEAK Matrix assessment added to the positive sentiment, underscoring its capabilities in analytics and automation for payers. I also checked this using Tickeron’s AI Screener to see how the stock stacks up against industry peers.

Trading volume rose with the rally, as shares tested highs amid commentary on new business wins. Without major earnings or deals taking center stage, these elements shifted sentiment and lifted the price from oversold territory.

What Shaped CNDT's Quarterly Performance

CNDT's performance over the quarter balanced company-specific hurdles with core strengths. Q4 2025 earnings, released in February, reported a net loss of $0.09 per share—wider than the expected $0.06 loss—alongside stable revenue of around $770 million. This miss sparked a sell-off, driving shares to $1.15 lows in March amid market caution on profitability.

Positive notes from the earnings call helped offset this, including $152 million in new business ACV, up 11% year-over-year, especially in transportation and government segments. Institutional ownership at 73% offered a floor, and steady demand for government outsourcing amid fiscal spending supported stabilization. These factors combined for a modest net gain despite the volatility.

Trending AI Robots

One resource I rely on for ideas is Tickeron's Trending AI Robots page, which highlights top-performing AI trading bots from its library of hundreds of algorithms trading thousands of tickers. These bots are selected based on recent performance metrics, win rates, and market relevance, covering strategies like momentum, mean reversion, and sector-specific plays for day trades or swings. With transparent tracking of returns, drawdowns, and Sharpe ratios, it's a practical way to explore diversification or backtest concepts that fit your approach.

CNDT Stock Outlook: Key Factors to Watch

For CNDT, I'm watching upcoming Q1 2026 earnings closely, as they should clarify revenue trends and ACV growth in transportation and healthcare. Progress on AI-enhanced services and new contracts could sway sentiment. Industry trends in business process outsourcing, including government budget demands, stay important. Macro factors like interest rates impacting spending and healthcare regulatory shifts are worth tracking too. On the risk side, execution toward profitability and competition in automation remain key concerns.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: CNDT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CNDT in upward trend: price rose above 50-day moving average on August 20, 2026

CNDT moved above its 50-day moving average on August 20, 2026 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where CNDT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for CNDT crossed bullishly above the 50-day moving average on July 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CNDT advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 147 cases where CNDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CNDT moved out of overbought territory on August 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNDT as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CNDT turned negative on August 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CNDT broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.476) is normal, around the industry mean (7.110). P/E Ratio (13.615) is within average values for comparable stocks, (70.841). CNDT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.226). CNDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (0.085) is also within normal values, averaging (147.745).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CNDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 9.37B. The market cap for tickers in the group ranges from 0 to 222.04B. IBM holds the highest valuation in this group at 222.04B. The lowest valued company is ARSC at 0.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 19%. JFU experienced the highest price growth at 30%, while WYFI experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 6%. For the same stocks of the Industry, the average monthly volume growth was 1% and the average quarterly volume growth was -21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 63
Price Growth Rating: 57
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
CNDT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of business process outsourcing services

Industry InformationTechnologyServices

Profile
Details
Industry
Miscellaneous Commercial Services
Address
100 Campus Drive
Phone
+1 844 663-2638
Employees
51000
Web
https://www.conduent.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.